MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
FLNA — Filana Therapeutics, Inc. Common Stock
NasdaqFilana Therapeutics, Inc. Common Stock
$0.93
-0.03(-3.53%)
- O
- 0.97
- H
- 1.04
- L
- 0.93
- V
- 1.67M
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About FLNA
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateJul 14, 2000
Employees20
Stock ExchangeNasdaq
Ticker SymbolFLNA
Websitehttps://www.filanatx.com
Key Financial Statistics
| Market Cap | $44.97M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.67 - $4.98 |
| 52-Week Avg Volume | 1.16M |
| VWAP | $1.01 |
| Transactions | 6,561 |
| Total Recorded Bars | 6,593 days |